ARTICLE | Clinical News
Ropinirole: Phase III started
May 11, 2015 7:00 AM UTC
Hisamitsu began a double-blind, Japanese Phase III trial of once-daily transdermal HP-3000 in patients receiving L-dopa. Patients will receive HP-3000 plus an oral placebo; once-daily oral ropinirole ...